Hemogenyx Pharmaceuticals plc

(“Hemogenyx Pharmaceuticals” or the “Company”)

 

Director/PDMR Shareholding

 

Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that it has been notified that Andrew Wright, the Company’s Financial Controller and Company Secretary (PDMR), has purchased 94,882 ordinary shares of £0.01 each in the Company (“Ordinary Shares”) at an average price of 6.03p per share. Following this transaction, Mr Wright has a total beneficial interest in 1,626,991 Ordinary Shares, representing approximately 0.36 per cent of the Company’s issued share capital.

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation No 596/2014 until the release of this announcement.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1. Details of PDMR/person closely associated with them (“PCA”)
a) Name Andrew Wright
b) Position/status PDMR: Financial Controller and Company Secretary
c) Initial notification/
amendment
Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument Ordinary shares of Hemogenyx Pharmaceuticals plc
Identification code GB00BYX3WZ24
b) Nature of the transaction Standalone acquisition of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
GBP £0.0603 94,882

 

 

d) Aggregated information

–        Aggregated volume

–        Price

Price(s) Volume(s)
GBP £5,721.38 94,882
e) Date of the transaction 2021-03-08
f) Place of the transaction London Stock Exchange
XLON

 

Enquiries:

Hemogenyx Pharmaceuticals plc https://hemogenyx.com
Dr Vladislav Sandler, Chief Executive Officer & Co-Founder headquarters@hemogenyx.com
Peter Redmond, Director peter.redmond@hemogenyx.com
SP Angel Corporate Finance LLP Tel: +44 (0)20 3470 0470
Matthew Johnson, Vadim Alexandre, Adam Cowl
Peterhouse Capital Limited Tel: +44 (0)20 7469 0930
Lucy Williams, Duncan Vasey, Charles Goodfellow